<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00546975</url>
  </required_header>
  <id_info>
    <org_study_id>07.33.CLI</org_study_id>
    <nct_id>NCT00546975</nct_id>
  </id_info>
  <brief_title>Effect of Oral Nutritional Supplements With Specialized Nutrients on Functional Recovery and Morbidity After Gastrointestinal Surgery</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Nutritional supplementation in postoperative recovery is still debated. Functional impairment&#xD;
      is known to develop both secondary to inflammatory processes or secondary to reduced&#xD;
      nutritional intake (e.g. disease induced anorexia). Since major surgery represents a&#xD;
      traumatic event, surgical patients are at increased risk of malnutrition due to starvation,&#xD;
      activation of neuroendocrine stress axis, inflammation and the subsequent increase in&#xD;
      metabolic rate. Gastrointestinal surgery in particular can create additional problems as it&#xD;
      often directly affects and limits dietary intake postoperatively and these effects frequently&#xD;
      continue after discharge. Whereas manifest malnutrition occurs in about 15% of general&#xD;
      surgical patients and in about 40% of oncology patients, postoperative weight loss of 5 to 9%&#xD;
      occur in all surgical patients during the first two months. Moreover studies have shown that&#xD;
      the nutritional status generally declines in hospital and both functional and nutritional&#xD;
      status deteriorate for two months after discharge in malnourished surgical patients.&#xD;
&#xD;
      Most studies that have investigated nutritional support in the surgical setting have&#xD;
      concentrated on perioperative or short term postoperative supplementation and focussed on&#xD;
      in-hospital infection and complication rate.&#xD;
&#xD;
      Hypothesis I:&#xD;
&#xD;
      Nutritional intake is decreased after surgery which results in an impaired nutritional status&#xD;
      which in turn is associated with a decreased functional status. Protein rich nutritional&#xD;
      supplementation is able to reverse nutritional depletion and restore functionality.&#xD;
&#xD;
      Hypothesis II:&#xD;
&#xD;
      Surgical stress leads to inflammation; inflammation - in addition to reduced nutritional&#xD;
      intake - impairs functional status and increases morbidity. Anti-inflammatory, protein rich&#xD;
      nutritional supplementation aims to prevent inflammatory complications and therefore improves&#xD;
      functional status and reduces morbidity. In patients with high risk for inflammation, a&#xD;
      higher effect of anti-inflammatory oral nutrition on recovery of functional status is&#xD;
      expected.&#xD;
&#xD;
      This study aims to determine whether 4 week oral nutritional supplementation and/ or&#xD;
      specialized nutrients is effective in restoring functional status and reducing morbidity in&#xD;
      surgical patients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Compliance unacceptably low.&#xD;
  </why_stopped>
  <start_date>October 2007</start_date>
  <completion_date type="Actual">September 2009</completion_date>
  <primary_completion_date type="Actual">September 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Physical Component Summary (from SF 36 Quality of life questionnaire)</measure>
    <time_frame>4 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>hand grip strength</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <condition>Patients Following Gastrointestinal Surgery</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Resource Support® Novartis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Resource Protein®, Novartis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Resource Support®</intervention_name>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Resource Protein®</intervention_name>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients who are &gt; 50 years of age and &lt; 80 years&#xD;
&#xD;
          2. Patients who have signed a written Informed Consent (Appendix I) prior to admission to&#xD;
             the study.&#xD;
&#xD;
          3. Patients who have an ECOG performance status (presurgery) of 0, 1 or 2 (Appendix II).&#xD;
&#xD;
          4. Patients able to orally consume 500 mL or more of liquid a day after adaption&#xD;
&#xD;
          5. Patients undergoing elective gastrointestinal surgery [e.g. Colorectal surgery:&#xD;
             colectomy, hemicolectomy, proctectomy; Small bowel resection/surgery; liver resection,&#xD;
             splenectomy, non-whipple pancreatic surgery]&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients who are &gt; 80 years of age and &lt; 50 years&#xD;
&#xD;
          2. Patients who have co-morbid conditions, uncontrolled metabolic conditions or&#xD;
             psychiatric conditions that might make tolerance or evaluation of the feeding formula&#xD;
             difficult;&#xD;
&#xD;
          3. Patients undergoing Whipple´s procedure, gastrectomy, oesophageal resection&#xD;
&#xD;
          4. Patients who get preoperative nutritional support&#xD;
&#xD;
          5. Patients taking supplements (EPA, DHA)&#xD;
&#xD;
          6. Any concomitant severe disease e.g.&#xD;
&#xD;
               -  Patients with respiratory failure (FEV&lt;0.8l/sec)&#xD;
&#xD;
               -  Patients with renal failure (Cr &gt; 3mg/dl or dialysis patients)&#xD;
&#xD;
               -  Patients with hepatic dysfunction (Child &gt;A)&#xD;
&#xD;
               -  Patients with cardiac failure (NYHA &gt; III)&#xD;
&#xD;
          7. Patients suffering from an intestinal obstruction or ileus&#xD;
&#xD;
          8. Patients with an Hb level of &gt;8 g/dL experiencing gastrointestinal haemorrhaging&#xD;
&#xD;
          9. Patients with HIV&#xD;
&#xD;
         10. Patients requiring immunosuppression treatments&#xD;
&#xD;
         11. Pregnancy&#xD;
&#xD;
         12. Patients undergoing emergency surgery&#xD;
&#xD;
         13. Other patients determined by a study investigator to be inappropriate for enrolment in&#xD;
             this study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Herbert Lochs, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Charite Universitätsmedizin Berlin Dept. of Gastroenterology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dept of Surgery CCM</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2007</verification_date>
  <study_first_submitted>October 18, 2007</study_first_submitted>
  <study_first_submitted_qc>October 18, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 19, 2007</study_first_posted>
  <last_update_submitted>June 24, 2011</last_update_submitted>
  <last_update_submitted_qc>June 24, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 27, 2011</last_update_posted>
  <responsible_party>
    <name_title>Prof Herbert Lochs</name_title>
    <organization>Charite University Medicine</organization>
  </responsible_party>
  <keyword>gastrointestinal surgery</keyword>
  <keyword>nutritional intervention</keyword>
  <keyword>functional status</keyword>
  <keyword>quality of life</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

